Relationship between increased bone mineral density and PTH receptor gene expression by human PTH (1-84) in OVX rats.

被引：0
作者：
Horiuchi, N [1 ]
机构：
[1] Ohu Univ, Dept Biochem, Sch Dent, Koriyama, Fukushima, Japan
来源：
JOURNAL OF DENTAL RESEARCH | 1999年 / 78卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R78 [口腔科学];
学科分类号：
1003 ;
摘要：
引用
收藏
页码：1125 / 1125
页数：1
相关论文
共 50 条
  • [31] Treatment of ovariectomized skeletally-mature rhesus monkeys with recombinant human parathyroid hormone 1-84 (PTH) for 16 months increases bone density and strength at the lumbar spine
    Fox, J.
    Miller, M. A.
    Turner, C. H.
    Smith, S. Y.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S237 - S237
  • [32] Association study of polymorphisms of the estrogen receptor (ER) gene and parathyroid hormone(PTH) gene and bone mineral density in Beijing Han Women
    Xue, Y
    Li, D
    Wang, Q
    BONE, 2003, 32 (05) : S127 - S127
  • [33] Abaloparatide, a Selective PTH1 Receptor Agonist, Reversed Bone Loss and Improved Trabecular Architecture in Orchiectomized Rats.
    Chandler, Heidi
    Mullarkey, Tara
    Stewart, Rachel
    Hattersley, Gary
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 : S275 - S275
  • [34] Increased uniformity in bone mineralization after combined treatment of PTH-(1-34) and OPG in osteopenic ovariectomized rats.
    Roschger, P
    Valenta, A
    Fratzl-Zelman, N
    Kostenuik, PJ
    Dunstan, CR
    Fratzl, P
    Klaushofer, K
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S384 - S384
  • [35] THE RELATIONSHIP BETWEEN 25-HYDROXY VITAMIN D AND PTH AND BONE MINERAL DENSITY IN HEALTHY PEOPLE IN PUTIAN AREA IN FUJIAN
    Wang, G.
    Yang, J.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S354 - S355
  • [36] RELATIONSHIP BETWEEN BONE MINERAL DENSITY, PTH, VITAMIN D AND INSULIN-LIKE GROWTH FACTOR-1 IN POSTMENOPAUSAL WOMEN WITH SECONDARY HYPERPARATHYROIDISM
    Loriggiola, L.
    Camozzi, V. I.
    Luisetto, G.
    Basso, S. M. M.
    Lumachi, F.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S213 - S213
  • [37] DIFFERENCES IN BINDING AFFINITIES OF HUMAN PTH(1-84) DO NOT ALTER BIOLOGICAL POTENCY - A COMPARISON BETWEEN CHEMICALLY SYNTHESIZED HORMONE, NATURAL AND MUTANT FORMS
    OLSTAD, OK
    MORRISON, NE
    JEMTLAND, R
    JUPPNER, H
    SEGRE, GV
    GAUTVIK, KM
    PEPTIDES, 1994, 15 (07) : 1261 - 1265
  • [38] THE ASSOCIATION BETWEEN sRANKL/OPG SYSTEM, SERUM PTH AND VOLUMETRIC BONE MINERAL DENSITY IN GROWING RATS WITH EXPERIMENTAL CHRONIC KIDNEY DISEASE
    Znorko, Beata
    Pawlak, Dariusz
    Oksztulska-Kolanek, Ewa
    Domaniewski, Tomasz
    Roszczenko, Alicja
    Rogalska, Joanna
    Brzoska, Malgorzata Michalina
    Pawlak, Krystyna
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [39] Bone turnover markers and BMD remain elevated in postmenopausal osteoporotic women through a full 24 months of treatment with human parathyroid hormone 1-84 (PTH).
    Greenspan, S. L.
    Hanley, D. A.
    Morris, S.
    Marriott, T. B.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S114 - S114
  • [40] One year of abaloparatide, a selective peptide activator of the PTH1 receptor, increased bone mass and strength in ovariectomized rats
    Varela, Aurore
    Chouinard, Luc
    Lesage, Elisabeth
    Guldberg, Robert
    Smith, Susan Y.
    Kostenuik, Paul J.
    Hattersley, Gary
    BONE, 2017, 95 : 143 - 150
12345